{
  "company": {
    "name": "Sinaptica Therapeutics",
    "website": "https://sinapticatx.com/",
    "record": "https://startuphistory.org/c/sinapticatx.com"
  },
  "status": null,
  "history_since": "2026-11-12T11:43:38.900Z",
  "baseline": {
    "snapshot_id": "7739b4614f17fa70e71c54a81213b77d9b111e406677d83439cdce0059294be6",
    "observed_at": "2026-11-12T11:43:38.900Z",
    "headline": "Noninvasive Neuromodulation: A True Breakthrough in Alzheimer's Disease",
    "description": "Sinaptica Therapeutics™ has developed a breakthrough personalized closed-loop neuromodulation therapy for Alzheimer’s Disease that works by enhancing neuroplasticity via neurostimulation of key brain ",
    "evidence": "https://sinapticatx.com/",
    "evidence_kind": "live_capture",
    "facts": {
      "version": 1,
      "pages": [
        {
          "page": "home",
          "customers": [],
          "investors": [],
          "prices": [],
          "compliance": [
            "FDA-APPROVED"
          ],
          "funding": []
        }
      ]
    },
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-12T11:43:38.900Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-12T11:43:38.900Z",
      "variants": [
        {
          "headline": "Noninvasive Neuromodulation: A True Breakthrough in Alzheimer's Disease",
          "subhead": "Sinaptica Therapeutics™ has developed a breakthrough personalized closed-loop neuromodulation therapy for Alzheimer’s Disease that works by enhancing neuroplasticity via neurostimulation of key brain ",
          "observed_at": "2026-11-12T11:43:38.900Z",
          "evidence": "https://sinapticatx.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Noninvasive Neuromodulation: A True Breakthrough in Alzheimer's Disease",
      "subhead": "Sinaptica Therapeutics™ has developed a breakthrough personalized closed-loop neuromodulation therapy for Alzheimer’s Disease that works by enhancing neuroplasticity via neurostimulation of key brain ",
      "from": "2026-11-12T11:43:38.900Z",
      "to": "2026-11-12T11:43:38.900Z",
      "captures": 1,
      "evidence": "https://sinapticatx.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "on": "2026-11-12T11:43:38.900Z"
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "same_space": [
    {
      "name": "Switch Therapeutics",
      "record": "https://startuphistory.org/c/switchthera.com",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "SiteOne Therapeutics",
      "record": "https://startuphistory.org/c/siteonetx.com",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "Cybin",
      "record": "https://startuphistory.org/c/cybin.com",
      "basis": "category",
      "category": "CNS and neurodegeneration therapeutics"
    },
    {
      "name": "Inovia Bio",
      "record": "https://startuphistory.org/c/inovia.bio",
      "basis": "category",
      "category": "CNS and neurodegeneration therapeutics"
    },
    {
      "name": "Sironax",
      "record": "https://startuphistory.org/c/sironax.com",
      "basis": "category",
      "category": "CNS and neurodegeneration therapeutics"
    },
    {
      "name": "Modulight Biotherapeutics",
      "record": "https://startuphistory.org/c/modulight.bio",
      "basis": "category",
      "category": "CNS and neurodegeneration therapeutics"
    }
  ],
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Sinaptica Therapeutics” company record, https://startuphistory.org/c/sinapticatx.com"
}